MTNR1B and gestational diabetes: Both the Finnish study [24] and our analysis assessed the effect of MTNR1B rs10830963 genotype in pregnant Caucasian women and had a primary outcome of reaching/exceeding the pre-defined glycemic targets (for GDM diagnosis/AIT initiation, respectively) after a period of MNT and lifestyle intervention in high risk pregnant/GDM individuals.